Broad spectrum antihelminthic
The core concept here is understanding the mechanism and spectrum of antihelminthic drugs. Broad-spectrum means effective against multiple types of parasitic worms. Albendazole and mebendazole inhibit microtubule formation in worms, which is crucial for their cellular functions. This mechanism is different from other drugs like ivermectin, which is more specific to certain parasites.
Now, looking at the options. Suppose the correct answer is C, which is albendazole. Then the other options might include drugs like pyrantel pamoate (which is for roundworms and hookworms but not broad), metronidazole (an antiprotozoal, not antihelminthic), and ivermectin (used for specific parasites like filarial worms and onchocerca). Each of these is incorrect because they either have a narrower spectrum or are used for different types of parasites.
The clinical pearl would be to remember that albendazole and mebendazole are the primary broad-spectrum antihelminthics. Also, note that metronidazole is for protozoa and not helminths, which is a common confusion point. Ivermectin is another drug that's often mixed up but is more specific. So students should be clear on the different drug classes and their uses.
**Core Concept**
Broad-spectrum antihelminthics target multiple helminth species (e.g., nematodes, cestodes, trematodes) by disrupting critical parasitic pathways. **Albendazole** and **mebendazole** are prototypical agents that inhibit microtubule polymerization in worms, impairing glucose uptake and ATP production.
**Why the Correct Answer is Right**
**Albendazole** is a benzimidazole that binds to Ξ²-tubulin in helminth cells, preventing microtubule formation. This disrupts intracellular transport, energy metabolism, and structural integrity, leading to worm death. It is effective against intestinal nematodes (e.g., *Ascaris*, *Trichuris*), cestodes (*Taenia*, *Echinococcus*), and some trematodes (*Fasciola*). Its broad spectrum and oral bioavailability make it a first-line agent for many helminthic infections.
**Why Each Wrong Option is Incorrect**
**Option A:** *Praziquantel* is **narrow-spectrum**, primarily targeting cestodes and trematodes but ineffective against nematodes.
**Option B:** *Ivermectin* acts on **invertebrate glutamate-gated chloride channels**, effective for strongyloidiasis and onchocerciasis but not broad-spectrum.
**Option D:** *Piperazine* is obsolete and only effective against **ascaridiasis**, lacking activity against cestodes or trematodes.
**Clinical Pearl / High-Yield Fact**
Remember